#news #biotech Ipsen pens early-stage, $14.5M programmed cell death cancer deal with BAKX Therapeutics

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Ipsen pens early-stage, $14.5M programmed cell death cancer deal with BAKX Therapeutics .Ipsen pens early-stage, $14.5M programmed cell death cancer deal with BAKX Therapeutics
badams
Wed, 07/28/2021 – 09:00

from FierceBiotech: Biotech https://ift.tt/3l5843R